Health forum discussion on Tenacibaculum
With the aim of stimulating discussion, the topic moderators would very much appreciate your answering the following questions:
In France, the survey done within the PathoTrackfish on Tenacibaculum infections has demonstrated that almost 50% of the strains isolated during clinical outbreaks were not Tenacibaculum maritimum. Have you ever noticed any differences in the clinical symptoms of Tenacibaculum infections which could suggest that different strains are present in your area or your country?
Co-infections (with different strains of Tenacibaculum or with Vibrio, such as Vibrio harveyi) are being reported, which can affect the therapy efficacy. Have you noticed any increasing pitfalls of treatments which could be eventually explained by co-infections?
When performing a cost-benefit analysis for Tenacibaculum infection in your epidemiological context, would you consider developing a vaccination a worse strategy?
Would you propose any other issue related to this topic (Tenacibaculum) that has not been addressed and that you would like the moderators to address?
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google.
Terms of Service